Recent Updates
Recently added Catalysts
PLRX Positive Sentiment

Pliant Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Wednesday, January 3, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Pliant Therapeutics, Inc. has announced that its CEO, Dr. Bernard Coulie, will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024. The event is scheduled to start at 7:30 a.m. Pacific Time and will take place at the Westin St. Francis Hotel in San Francisco. Interested stakeholders can access the live presentation via the company’s website, with a replay available for 30 days post-event.
Price reaction · baseline $17.96 (2024-01-02 close) · hit after-hours · clean, no other PLRX news in the window
day 0 close · peak
+0.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • Pliant Therapeutics is participating in a prominent healthcare conference.
  • The event provides an opportunity for increased visibility and engagement.
  • Live webcast allows broader access to the presentation.
  • The replay availability for 30 days extends reach beyond the live event.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+47%
120-day peak, hindsight
Typical move
1.5%
average across 6 past catalysts
Cash runway
~37 mo
Minimal dilution risk
Lead asset
PLN-101095
Phase 1 · Advanced or Metastatic Solid Tumor

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that Bernard Coulie, M.D., Ph.D., President and Chief Executive Officer, is scheduled to present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 7:30 a.m. Pacific Time at the Westin St. Francis Hotel in San Francisco.
Interested parties may access the live webcast of this presentation by visiting the Investors & Media section of Pliant’s website at www.PliantRx.com. The replay of this webcast will be archived for 30 days following the conclusion of the event.
About Pliant Therapeutics, Inc.
Investor and Media Contact:
Vice President, Investor Relations and Corporate Communications
Pliant Therapeutics, Inc.

Frequently Asked Questions

When is Pliant Therapeutics' presentation at the J.P. Morgan Conference?

Pliant Therapeutics will present on January 9, 2024, at 7:30 a.m. PT.

Who is presenting for Pliant Therapeutics at the conference?

Bernard Coulie, M.D., Ph.D., is the presenter for Pliant Therapeutics.

How can I access the live webcast of the presentation?

The live webcast can be accessed through the Investors & Media section on Pliant's website.

How long will the webcast replay be available?

The webcast replay will be available for 30 days after the event.

Where is the conference being held?

The conference will take place at the Westin St. Francis Hotel in San Francisco.

ShareAdd on Google
Tags: PLRX Viatris Investor Conferences Healthcare Pliant Therapeutics J.P. Morgan Healthcare Conference Bernard Coulie San Francisco
Last updated: Jan 3, 2024

Biotech snapshot

Cash runway
$158M liquidity · $4M/mo burn
~37 mo
Minimal dilution risk
Lead asset
PLN-101095Phase 1
Advanced or Metastatic Solid Tumor →

Catalyst track record

+47%
best trade around PLRX's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for PLRX.

See every catalyst's timing & PoA →